|
GR860984B
(en)
|
1985-04-17 |
1986-08-18 |
Zymogenetics Inc |
Expression of factor vii and ix activities in mammalian cells
|
|
AU2798599A
(en)
|
1998-02-27 |
1999-09-15 |
Bioelastics Research Ltd. |
Injectable implants for tissue augmentation and restoration
|
|
US20090148906A1
(en)
|
1998-09-29 |
2009-06-11 |
Shire Human Genetic Therapies, Inc. A Delaware Corporation |
Optimized messenger rna
|
|
US6361771B1
(en)
|
1999-04-06 |
2002-03-26 |
Neurotech S.A. |
ARPE-19 as a platform cell line for encapsulated cell-based delivery
|
|
CA2445568A1
(en)
|
2001-04-27 |
2002-11-07 |
Vertex Pharmaceuticals Incorporated |
Triazole-derived kinase inhibitors and uses thereof
|
|
WO2004064971A2
(en)
|
2003-01-23 |
2004-08-05 |
Inotech Ag |
Process for preparing microcapsules having an improved mechanical resistance
|
|
PE20080906A1
(es)
|
2006-08-17 |
2008-07-05 |
Kemia Inc |
Derivados heteroarilo como inhibidores de citocina
|
|
US20080242694A1
(en)
|
2006-09-18 |
2008-10-02 |
D Sidocky Neil R |
Amino-substituted heterocycles, compositions thereof, and methods of treatment therewith
|
|
WO2010005533A2
(en)
|
2008-06-30 |
2010-01-14 |
The Johns Hopkins University |
Compositions and methods for the treatment of ocular oxidative stress and retinitis pigmentosa
|
|
AU2010206374B2
(en)
|
2009-01-23 |
2013-01-17 |
Gloriana Therapeutics Sarl |
Improved cell lines and their use in encapsulated cell biodelivery
|
|
JP5725475B2
(ja)
|
2010-01-21 |
2015-05-27 |
公立大学法人名古屋市立大学 |
ヒドロキサム酸誘導体及びそれを用いたｈｄａｃ８阻害剤
|
|
US9867781B2
(en)
|
2011-02-18 |
2018-01-16 |
Massachusetts Institute Of Technology |
Hydrogel encapsulated cells and anti-inflammatory drugs
|
|
DK3354665T5
(da)
|
2011-06-02 |
2022-09-19 |
Massachusetts Inst Technology |
Modificerede alginater til celleindkapsling og celleterapi
|
|
WO2013151665A2
(en)
|
2012-04-02 |
2013-10-10 |
modeRNA Therapeutics |
Modified polynucleotides for the production of proteins associated with human disease
|
|
US9555007B2
(en)
|
2013-03-14 |
2017-01-31 |
Massachusetts Institute Of Technology |
Multi-layer hydrogel capsules for encapsulation of cells and cell aggregates
|
|
ES2845473T3
(es)
|
2013-03-14 |
2021-07-26 |
Boehringer Ingelheim Int |
(Bencil-ciano-metil)-amidas sustituidas de ácido 2-aza-biciclo[2.2.1]heptano-3-carboxílico inhibidores de la catepsina- C
|
|
US10172791B2
(en)
|
2013-03-14 |
2019-01-08 |
Massachusetts Institute Of Technology |
Multi-layer hydrogel capsules for encapsulation of cells and cell aggregates
|
|
GB201304973D0
(en)
|
2013-03-19 |
2013-05-01 |
Profactor Pharma Ltd |
Recombinant protein
|
|
ITTO20130356A1
(it)
|
2013-05-03 |
2014-11-04 |
Uni Degli Studi Del Piemonte Orientale Ame |
Inibitori di nicotinamide fosforibosil transferasi, relative composizioni, prodotti ed usi
|
|
WO2014182684A2
(en)
|
2013-05-06 |
2014-11-13 |
Cell Machines, Inc. |
Methods and compositions related to large scale production of proteins
|
|
CA2922483A1
(en)
|
2013-09-11 |
2015-03-19 |
Neurotech Usa, Inc. |
Encapsulated cell therapy cartridge
|
|
PL3628334T3
(pl)
|
2014-03-21 |
2023-12-18 |
Genzyme Corporation |
Terapia genowa w retinopatii barwnikowej
|
|
CN104072478B
(zh)
|
2014-05-22 |
2016-06-01 |
大连理工大学 |
一类萘环4位含1,2,3-三唑的萘酰亚胺衍生物的合成及其应用
|
|
US11008561B2
(en)
|
2014-06-30 |
2021-05-18 |
Bioverativ Therapeutics Inc. |
Optimized factor IX gene
|
|
KR102719485B1
(ko)
|
2014-08-01 |
2024-10-21 |
메사추세츠 인스티튜트 오브 테크놀로지 |
항-섬유 물질 및 응용을 위한 변형된 알기네이트
|
|
EP3297693A1
(en)
|
2015-05-17 |
2018-03-28 |
Massachusetts Institute of Technology |
Multi-layer hydrogel capsules for encapsulation of cells and cell aggregates
|
|
JPWO2017018086A1
(ja)
|
2015-07-29 |
2018-02-01 |
Ｎｉｓｓｈａ株式会社 |
マイクロニードルシート
|
|
IL242380A0
(en)
|
2015-10-29 |
2016-02-01 |
Yeda Res & Dev |
A method of inducing cardiomyocytes proliferation and treating heart diseases
|
|
AU2016344041B2
(en)
|
2015-11-01 |
2019-11-07 |
Massachusetts Institute Of Technology |
Materials with improved properties
|
|
NZ742800A
(en)
*
|
2015-11-01 |
2019-03-29 |
Massachusetts Inst Technology |
Modified alginates for anti-fibrotic materials and applications
|
|
CA3012695A1
(en)
|
2016-02-01 |
2017-08-10 |
Bioverativ Therapeutics Inc. |
Optimized factor viii genes
|
|
WO2017201328A1
(en)
|
2016-05-18 |
2017-11-23 |
Modernatx, Inc. |
POLYNUCLEOTIDES ENCODING α-GALACTOSIDASE A FOR THE TREATMENT OF FABRY DISEASE
|
|
KR20190092374A
(ko)
*
|
2016-10-03 |
2019-08-07 |
시질론 테라퓨틱스, 인크. |
화합물, 장치, 및 이의 용도
|
|
WO2018206168A1
(en)
|
2017-05-11 |
2018-11-15 |
Zentrum Für Forschungsförderung In Der Pädiatrie Gmbh |
Concept for the treatment of monogenetic disorders
|
|
EP3687580A1
(en)
|
2017-09-27 |
2020-08-05 |
Sigilon Therapeutics, Inc. |
Methods, compositions, and implantable elements comprising active cells
|
|
US20210145889A1
(en)
|
2018-04-04 |
2021-05-20 |
Sigilon Therapeutics, Inc. |
Methods, compositions, and implantable elements comprising stem cells
|